Cargando…
Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis
BACKGROUND AND AIMS: Portal vein thrombosis is a serious adverse event that occurs during liver cirrhosis. We performed a meta-analysis to evaluate the safety and efficacy of anticoagulant therapy and prophylactic anticoagulant therapy in cirrhosis patients with (/without) portal vein thrombosis. ME...
Autores principales: | Chen, Huan, Lei, Jiaming, Liang, Sicheng, Luo, Gang, Deng, Mingming, Lü, Muhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102101/ https://www.ncbi.nlm.nih.gov/pubmed/34007837 http://dx.doi.org/10.1155/2021/8859602 |
Ejemplares similares
-
Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis
por: Ghazaleh, Sami, et al.
Publicado: (2021) -
Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis
por: Xie, Luwen, et al.
Publicado: (2022) -
Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis
por: Lu, Wenming, et al.
Publicado: (2023) -
Anticoagulation in cirrhosis: a new paradigm?
por: Leonardi, Filippo, et al.
Publicado: (2017) -
Research progress on the interactions between long non-coding RNAs and microRNAs in human cancer
por: Sun, Binyu, et al.
Publicado: (2020)